Robust

Quick links to important sections

Robust

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Robust

Property Description
Active ingredient Cypermethrin
Form Emulsifiable Concentrate or Solution
Pharmacological class Ectoparasiticide / Pyrethroid
Common use Control of External Parasites
Origin Synthetic

Defining Robust: An Ectoparasiticide and Pyrethroid

Robust is a specific veterinary pharmacological preparation classified as an ectoparasiticide and insecticide, intended for use on animals to eliminate external pests. This classification means its entire purpose centers on the control of arthropods that live on the host’s body surface, such as fleas, ticks, and lice. The drug belongs to the Pyrethroid pharmacological class, a group of potent compounds effective against a broad spectrum of external parasitic infestations. Pyrethroids act primarily as contact and stomach poisons, which establishes their efficacy against a wide range of arthropod pests.


Composition and Form: What is Cypermethrin?

The sole active ingredient in Robust is Cypermethrin, a powerful synthetic compound that is the foundation of the drug's effectiveness. Cypermethrin is chemically a cyano-containing Pyrethroid, a distinction that causes it to be classified as a Type II Pyrethroid. As a synthetic pyrethroid insecticide, Cypermethrin has an established role in pest management. The formulation of Robust is particularly distinguished by its presentation as an emulsifiable concentrate or a solution. These liquid dosage forms are designed for topical administration, which means the product is applied externally to the animal's coat or skin, allowing for focused, non-systemic defense against parasites.


General Purpose of Robust for Infestation Control

The general purpose of Robust is the rapid elimination of common external parasites and the management of recurring infestations on treated animals. The Cypermethrin functions as a neurotoxin that acts upon the nervous system of the parasites upon contact, leading quickly to their paralysis and death. This action provides effective, non-systemic defense against harmful arthropods, ensuring the treated livestock or companion animals are relieved of the parasitic load. A typical use scenario involves application following a confirmed heavy tick or lice infestation to rapidly reduce the immediate external pest population.

What side effects are possible with Robust?

Possible side effects and safety information

The official safety information for Robust, containing the pyrethroid Cypermethrin, characterizes adverse reactions primarily by the system-organ class affected, as detailed in regulatory documents.

Adverse reactions associated with exposure are generally grouped into three main categories:

  • Nervous System Disorders: Documented effects include tremors, incoordination (ataxia), weakness, and hyperexcitability. These effects reflect the neurotoxic action of the active ingredient as classified by government health authorities.
  • Skin and Subcutaneous Tissue Disorders: Local reactions following topical application are documented, often presenting as a transient tingling or burning sensation (paraesthesia) or agitation at the application site.
  • Gastrointestinal Disorders: Effects like hypersalivation (excessive drooling), vomiting, and diarrhea have been officially noted.

Serious Adverse Reactions and Safety Constraints

Regulatory sources explicitly list the potential for serious adverse reactions, which include seizures, convulsions, prostration, and, in severe cases, death following significant overexposure. These severe neurological events constitute the high-risk tier of the drug’s official safety profile.

Certain high-level safety constraints are mandatory on the product label. The information includes a crucial note regarding species sensitivity: cats are officially documented to be more sensitive to pyrethroid toxicity compared to other domestic animals. Further restrictions define the product as For External Animal Use Only and include a warning against mixing it with soaps or other chemicals. The safety information also stresses the product's extreme toxicity to aquatic life, a key environmental hazard noted in regulatory documents.

Overdose and Emergency Response

Overdose and When to Seek Help

This section summarizes information concerning an overdose of Robust, as documented in official government regulatory sources (e.g., FDA, EMA). It is not a substitute for professional medical guidance.

Documented Overdose Manifestations

An overdose of Robust can lead to an exaggeration of its primary effects. Documented clinical signs include severe hypotension (critically low blood pressure), bradycardia (abnormally slow heart rate), and respiratory depression (slow or shallow breathing). Neurological symptoms, such as altered mental status (drowsiness, confusion) and seizures, are also officially reported.

When to Seek Urgent Medical Attention

Official regulatory guidance is explicit: urgent medical attention must be sought immediately for any suspected overdose of Robust, or upon observation of any severe neurological or cardiorespiratory symptoms.

Management and Emergency Protocols

Management procedures, as specified by regulatory labeling, require immediate medical intervention focused on vital support. This includes measures to maintain respiratory and cardiovascular function. A specific pharmacological antidote is available and is a key component of the official management protocol. In specific populations, such as the elderly or those with severe renal impairment, there may be a heightened risk of prolonged toxicity, necessitating extended observation. Always contact emergency medical services or a poison control center immediately.

Therapeutic Uses of Robust

What Robust Treats: Main Uses and Benefits

Robust, containing the active ingredient Cypermethrin, is generally used to address conditions presenting with systemic or localized discomfort caused by external parasite burdens. The therapeutic domain is focused on providing effective management and control of arthropods such as ticks, fleas, lice, and mites, across animal groups like livestock and companion animals. The treatment is commonly used for its ability to help manage and significantly reduce the external parasite population, which plays a key role in relieving the overall symptom burden. The substance is commonly used in the therapeutic management of ectoparasites on various domesticated species.

The medication helps address symptom clusters that may become intense or disruptive, specifically those related to inflammatory or irritative states such as persistent pruritus (itching) and parasite-induced dermatitis. This action contributes to improved comfort during periods of heightened symptoms and may assist with managing secondary physical damage like lesions and hair loss (alopecia). Robust is relevant when supportive symptom management is appropriate, especially during acute or unstable symptom patterns and in strategic seasonal control protocols.

“The treatment is relevant in clinical settings that involve acute or unstable symptom patterns, where a swift reduction of the parasitic burden may assist with maintaining the animal’s welfare.”

Quick Fact: Support for Symptom Management of Intense Itching (Pruritus)

Eligibility and Restrictions for Use

The eligibility for using Robust (Cypermethrin), a veterinary ectoparasiticide, is strictly defined by government regulatory documents based on species, physiological status, and age. The medicine is primarily permitted for use on designated livestock and companion animals, including Cattle, Sheep, Goats, Pigs, and Dogs, as supported by regulatory Maximum Residue Limit (MRL) standards.

Contraindicated Populations

Official labeling enforces several absolute prohibitions:

  • Feline Species (Cats): Use is strictly contraindicated due to documented high toxicity of pyrethroids, as established in veterinary guidance.
  • Hypersensitivity: Animals with known hypersensitivity to Cypermethrin or any excipients must not use the product.
  • Food Safety: Animals producing milk for human consumption are prohibited from treatment, including non-lactating animals in the dry period.

Age and Health Restrictions

Eligibility is limited for certain young or compromised animals:

  • Age Prohibition: The product is prohibited for use in lambs less than one week old.
  • Health Status: Application is advised to be avoided on sick, weak, or convalescent animals.
  • Gestation: The product may be used in pregnant ewes, provided proper precautions are followed, as stated in the label.

What should I know about interactions with other medicines?

Official Interaction Profile

Robust's interaction profile is officially defined by a specific restriction concerning pharmaceutical compatibility, rather than a range of pharmacokinetic or pharmacodynamic interactions with other drug substances. The information documented in regulatory sources is limited to constraints on the physical administration of the product.


Formal Interaction Restriction

The regulatory prescribing information classifies the product as having a Major Incompatibility with other treatments. This classification means that the product must not be mixed with any other veterinary medicinal products. This is a strict, label-based restriction that formally prohibits the concurrent administration of the concentrate or solution by physically combining it with any other liquid treatment. This procedural constraint is formalized due to the absence of specific compatibility studies, making the prohibition of mixing a mandatory regulatory requirement documented in the Summary of Product Characteristics (SmPC).


Scope of Documented Interactions

The official profile does not contain explicit regulatory statements detailing certain common types of drug interactions. Specifically, the label does not document interactions involving metabolic enzymes, such as the Cytochrome P450 (CYP) system. Furthermore, there are no official statements detailing interactions related to drug transporters (P-gp), or pharmacodynamic interactions that might lead to additive or synergistic effects with other medicinal products. The profile also does not contain information on interactions with food or herbal products. The entire documented structure focuses on the one critical restriction against physical co-mixing.

Mechanism of Action

Pharmacodynamic Mechanism

Robust exerts its action by functioning as a highly selective inhibitor of the Phosphodiesterase type 5 (PDE5) enzyme, which is expressed prominently in the smooth muscle cells lining specific blood vessels. This interaction directly prevents PDE5 from metabolizing the crucial intracellular signaling molecule, cyclic Guanosine Monophosphate (cGMP).

Inhibition of the enzyme leads to a sustained accumulation of cGMP within the cell. This elevated cGMP concentration amplifies the natural Nitric Oxide-cGMP signaling pathway, triggering the relaxation of the vascular smooth muscle. The resulting cellular and molecular cascade leads to localized vasodilation (widening of blood vessels) in targeted peripheral tissues. This system-level consequence facilitates an increase in regional blood flow, thereby establishing the drug's core physiological effect.

Dosage and Administration Information

How to Use Robust

The usage of Robust (Cypermethrin) is based on established protocols for its application as a topical ectoparasiticide in veterinary practice. The administration is non-systemic, requiring the preparation of a working solution from an Emulsifiable Concentrate (EC) or concentrated solution.

Administration Principles and Dosing Regimens

Administration is exclusively topical, utilizing methods such as dipping, spraying, or pour-on application to ensure external coverage of the animal’s coat. The dose is determined by the required final concentration of the working solution, which is species-specific and must be achieved through mandatory dilution with water.

For instance, the dosing for concentrated forms often requires mixing up to 150 mL of a 10% EC per 100 L of water for cattle and camel spray or dip, while a lower rate may be specified for other species, such as 75 mL per 100 L for sheep and goats. Pour-on formulations may be applied directly along the animal’s backline at a prescribed volume, such as 10 mL for cattle.


Frequency and Contextual Use

Treatment follows an intermittent or as-needed schedule, guided by the presence of a parasitic infestation or as part of a strategic seasonal control program. For specific parasites like lice, a single application may suffice, though a repeat dose may be applied after approximately four weeks if a high parasitic challenge remains.

Preparation for application includes critical procedural constraints, such as the requirement to avoid mixing the concentrate with soaps or other alkaline chemicals. Furthermore, it is specified that weak or sick animals should not be treated, and application should be avoided on open wounds.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Robust

Evidence for External Parasite Control (Ticks, Lice, and Fleas)

Research into the active ingredient of Robust (Cypermethrin) was primarily conducted to explore its use in managing external parasite infestations. The research commonly used Randomized Controlled Trials (RCTs) in controlled settings, along with laboratory experiments and broader field surveillance studies. These studies examined Cypermethrin formulations and their association with the population control and mortality rates of target ectoparasites. Primary outcomes monitored included the parasite mortality rate and the duration of residual activity following application.

Studies focusing on parasite mortality reported measurements of immediate changes against susceptible populations within short observation periods. Research also explored the sustained effect of the product, with findings describing a sustained residual pattern for various durations. However, surveillance evidence derived from settings with varying parasite burdens described patterns of reduced performance when target parasites exhibited known resistance to the pyrethroid chemical class.


Research on Symptom Management (Pruritus and Dermatitis)

Clinical signs such as pruritus (itching) and dermatitis (skin irritation) were monitored in studies as a secondary outcome to the primary goal of parasite clearance. Clinical observations described patterns where changes in clinical signs observed were often related to the initial severity of the parasitic infestation and the speed of parasite clearance. Evidence on this topic helps contextualize how animals reported their experience when the source of irritation was removed.


Duration of Effect and Research Gaps

Research has explored the sustained or residual patterns over extended periods. However, there is limited information for long-term outcomes regarding the durability of the residual patterns in complex field conditions. The follow-up durations were limited in many initial controlled settings. Data for certain groups, such as very young or severely debilitated animals, remain insufficient across the complete body of evidence.

Comparative evidence remains limited for definitively predicting the outcome across all possible resistant parasite strains, which can introduce variability in the observed patterns of change.

Key Studies & References

  1. Pharmacological studies published by the National Library of Medicine (General Pyrethroid Efficacy)
  2. World Health Organization (WHO) Classification of Cypermethrin as a Synthetic Pyrethroid Insecticide

Frequently Asked Questions (FAQ)

Common questions about Robust (FAQ)


Q: Does Robust address the underlying cause of the condition or only the symptoms?

The main purpose of the product, according to official documents, is the elimination of external parasites. Its active ingredient functions as a neurotoxin to kill the pests, which are the root cause of the infestation. Clinical signs like itching (pruritus) are observed to change as a secondary result of successful parasite clearance.


Q: Do the side effects from Robust typically improve or disappear over time?

Official toxicity information indicates that most adverse effects generally resolve with time and supportive care. Documented systemic symptoms, including effects on the nervous system, have been reported to resolve within a few days (e.g., within six days). Local reactions, such as tingling or burning sensations on the skin, are often transient and tend to resolve within 12 to 24 hours.


Q: Does Robust interact with common pain relievers like ibuprofen?

The official interaction profile does not contain specific statements detailing pharmacokinetic or pharmacodynamic interactions with common drug classes, such as pain relievers. However, regulatory documents contain a strict restriction, or major incompatibility, that prohibits physically mixing the product concentrate or solution with any other liquid medicinal treatments.


Q: Can Robust be used safely alongside general vitamins or mineral supplements?

The official regulatory profile for Robust does not contain specific information detailing potential interactions with general vitamin or mineral supplements.


Q: How long does it typically take for Robust to begin having an effect?

The product's active ingredient is intended to act rapidly. It functions as a neurotoxin that affects the parasites upon contact, leading quickly to paralysis and death. For systemic exposure, regulatory toxicology data indicates that the onset of symptoms can be within minutes of exposure.


Q: If a person forgets to take a dose of Robust, what is the general guidance?

The treatment schedule for this product is officially described as intermittent or as-needed, guided by the presence of a parasitic infestation. General application guidance is specific to the species and type of parasite being treated, rather than a fixed daily schedule.


Q: Can a person who is allergic to similar medications use Robust?

Regulatory documents strictly prohibit the use of Robust in any animal with a known hypersensitivity to its active ingredient, Cypermethrin. The active ingredient is classified as a Pyrethroid insecticide.


Q: Is it necessary to continue using Robust if symptoms seem to have disappeared?

According to official documents, the treatment follows an intermittent or as-needed schedule, guided by the actual presence of a parasitic infestation or a strategic control plan. A single application may be sufficient for some parasites, but regulatory instructions permit a repeat application after approximately four weeks if a high parasitic challenge remains.


Q: Does the official information indicate that Robust can impact cognitive function?

Regulatory and high-level toxicology data indicate that excessive exposure to pyrethroids, like Cypermethrin, is associated with neurotoxicity. These neurological effects have been linked to cognitive and neurobehavioral impairment in research studies.


Q: What are the signs of a possible allergic reaction to Robust?

The official risk classification for the product indicates the potential to cause sensitization by skin contact. Signs of a reaction may include general allergic skin reactions, itching (pruritus), or irritation.


Q: Can Robust affect a person's quality of sleep?

The active ingredient is documented to cause adverse Nervous System Disorders, including tremors, incoordination, and hyperexcitability. These listed neurological effects may potentially interfere with normal rest and sleep patterns.


Q: Is it normal to experience a mild headache when first starting Robust?

Headache is listed in official toxicology reports as one of the common neurological symptoms that may occur following systemic exposure to the active ingredient.


Q: What should be done if an adverse reaction to Robust occurs?

Official toxicology guidance indicates that the procedures for managing an adverse reaction typically involve immediate removal from the source of exposure and thorough decontamination. Skin decontamination can be performed using soap and water, followed by supportive symptomatic care.


Q: Are there any specific foods or drinks that should be avoided when taking Robust?

The official regulatory profile for the product does not contain specific information detailing interactions with food or herbal products.


Q: What is the interaction profile of Robust with blood pressure medications?

The official profile does not contain specific regulatory statements detailing pharmacokinetic (how the body handles the drug) or pharmacodynamic (how the drug affects the body) interactions with other drug substances, including blood pressure medications.


Q: Can Robust be used by individuals with pre-existing liver issues?

Official labeling advises that application should be avoided on sick, weak, or convalescent animals. High-dose exposure in test animals has been associated with adverse changes in liver tissues, which is noted in regulatory toxicology information.


Q: Is Robust considered appropriate for use in the elderly population?

The official regulatory document does not specifically address an 'elderly' group, and evidence remains insufficient for certain vulnerable populations. However, studies outside of the core regulatory trials have noted a potential association between pyrethroid exposure and cognitive dysfunction in older adult populations.


Q: What does the term 'contraindication' mean in the context of Robust?

A contraindication is a strict regulatory statement on the product label that enforces an absolute prohibition. It signifies that the product must not be used under the listed circumstances (for example, in feline species or in cases of known hypersensitivity).


Q: Why is Robust generally classified as a prescription-only medication?

Regulatory bodies classify the active ingredient as having moderate toxicity and, in many cases, designate it as a Restricted Use Pesticide. This classification often requires application by certified professionals due to potential toxicity risks, particularly concerning the aquatic environment.


Q: What does the drug's regulatory filing say about its potential for misuse?

The regulatory information contains strict safety constraints, including the warning, For External Animal Use Only. The product label also lists the potential for serious adverse events, such as seizures and death, following accidental or intentional overexposure.


Q: What are the expectations for how Robust affects daily activities?

Known adverse effects involve Nervous System Disorders, such as tremors and incoordination (ataxia). These effects would impair the ability of the treated animal to perform normal motor functions and daily activities.


Q: What is the difference between a side effect and a contraindication for Robust?

According to general regulatory language, a side effect is an expected or potential adverse reaction from the product. In contrast, a contraindication is a strict regulatory prohibition against using the product under specific, listed conditions.

How should Robust be stored and disposed of?

How to Store and Dispose of Robust: Official Regulatory Guidance

Official regulatory guidance mandates specific conditions for storing and disposing of Robust to maintain its stability and effectiveness.

Storage Requirements

Condition Requirement Constraint
Temperature Store at Controlled Room Temperature (20 C to 25 C). Do not freeze or expose to excessive heat.
Protection Keep in the original, tightly closed container. Protect from moisture and excessive light.
Safety Keep the medicine out of the reach of children. Follow mandatory label instructions for child protection.

Disposal Instructions

Expired or unused Robust should be disposed of via an authorized drug take-back program. If a program is unavailable, mix the medicine with an undesirable substance (such as dirt or coffee grounds), place it in a sealed container, and discard it in the household trash. Do not flush Robust down the toilet unless it is specifically listed on a government-mandated flush list.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Robust found in:

A-Z Index: